Plato Investment Management’s Teladoc Health TDOC Stock Holding History

Plato Investment Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.94K	Hold	349	–	–	﹤0.01%	484
2026 Q1	$1.9K	Hold	349	–	–	﹤0.01%	498
2025 Q4	$2.46K	Hold	349	–	–	﹤0.01%	492
2025 Q3	$2.68K	Hold	349	–	–	﹤0.01%	498
2025 Q2	$3.03K	Buy	349 +27	+8%	+$196	﹤0.01%	500
2025 Q1	$2.59K	Sell	322 -1,420	-82%	-$14.4K	﹤0.01%	510
2024 Q4	$15.9K	Hold	1,742	–	–	﹤0.01%	537
2024 Q3	$16K	Hold	1,742	–	–	﹤0.01%	491
2024 Q2	$17K	Hold	1,742	–	–	﹤0.01%	436
2024 Q1	$26.3K	Hold	1,742	–	–	﹤0.01%	403
2023 Q4	$37.5K	Buy	+1,742	New	+$32.1K	0.05%	259

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Plato Investment Management's TDOC Position: Q2 2026 in Review

Plato Investment Management held its Teladoc Health (TDOC) position steady in Q2 2026 at 349 shares worth $2.94K. The position accounts for ﹤0.01% of the portfolio, ranked #484.

Plato Investment Management first reported a position in TDOC in Q4 2023 and has held it in 11 quarters since. The position peaked at $37.5K in Q4 2023. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

Plato Investment Management held 349 shares of Teladoc Health worth $2.94K as of Q2 2026.
Plato Investment Management left its Teladoc Health share count unchanged in Q2 2026.
Teladoc Health made up ﹤0.01% of Plato Investment Management's portfolio in Q2 2026, its #484 holding.
Plato Investment Management first reported a position in Teladoc Health in Q4 2023 and has held it in 11 quarters since.
Plato Investment Management's Teladoc Health position peaked at $37.5K in Q4 2023.
348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.